Martina Radić - Concepedia

Author

Martina Radić

Rudjer Boskovic Institute ORCID

Also Known As

M. Radić, Martina Radic, Martina Radić

Publications

208

Citations

H-Index

Concepts

All Affiliations

Rudjer Boskovic Institute University Hospital of Bern University of Trento University of Bern

About

Martina Radić is an author at Rudjer Boskovic Institute specializing in medicine, systems biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	34
2	Cell Biology	2	2	34
3	Natural Sciences	1	1	15
4	Cellular Physiology	1	1	15
5	Molecular Biology	1	1	15

Martina Radić

Publications

173

Citations

H-Index

Page 1

	Year	Citations
Accelerating histopathology workflows with generative AI-based virtually multiplexed tumour profiling Pushpak Pati, Sofia Karkampouna, Francesco Bonollo, Nature Machine Intelligence	2024	51
Altered Expression of Shorter p53 Family Isoforms Can Impact Melanoma Aggressiveness Ana Tadijan, Francesca Precazzini, Nikolina Hanžić, Cancers	2021	31
Expression profiles of p53/p73, NME and GLI families in metastatic melanoma tissue and cell lines Petar Ozretić, Nikolina Hanžić, Bastien Lucien Jean Proust, Scientific Reports	2019	25
NME6 is a phosphotransfer-inactive, monomeric NME/NDPK family member and functions in complexes at the interface of mitochondrial inner membrane and matrix Bastien Lucien Jean Proust, Martina Radić, Nikolina Škrobot Vidaček, Cell & Bioscience	2021	22
Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance Martina Radić, Ignacija Vlašić, Maja Jazvinšćak Jembrek, International Journal of Molecular Sciences Drug TargetingTargeted Therapy ResistanceCell SignalingMedicineVemurafenib-resistant Melanoma Cells	2022	19
The Subcellular Localization and Oligomerization Preferences of NME1/NME2 upon Radiation-Induced DNA Damage Martina Radić, Marko Šoštar, I.T. Weber, International Journal of Molecular Sciences Largest Fret EffectDna DamageRadiation EffectSubcellular LocalizationMolecular Biology	2020	15
Guidance of adjuvant instillation in intermediate-risk non-muscle invasive bladder cancer by drug screens in patient derived organoids: a single center, open-label, phase II trial Roland Seiler, Martin Egger, Marta De Menna, BMC Urology	2023	10

Page 1